A landmark study showing that aspirin can help prevent heart attacks was good news for most Americans last month. But the headlines came one day too soon for the influential New England Journal of Medicine, which published the original report. Newspapers and magazines routinely receive advance copies of the Journal each week on Monday but abide by an agreement not to report its contents before Wednesday at 6 p.m. The London-based Reuters news service seemed to violate the embargo by reporting the aspirin study on a Tuesday, more than 24 hours early. The incident has provoked a heated dispute over a...
To continue reading:
or
Log-In
